Home LiteratureArticle Details
PMID: 11141490 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

beta-site APP cleaving enzyme mRNA expression in APP transgenic mice: anatomical overlap with transgene expression and static levels with aging.

The American journal of pathology ·Vol. 158 ·No. 1 ·2001-01-00 ·Pages 173-7

Irizarry MC, Locascio JJ, Hyman BT

Abstract

The principal enzyme responsible for the beta-site cleavage of amyloid precursor protein (APP) in the brain is a membrane-bound aspartyl protease beta-site APP cleaving enzyme (BACE). We examined human APP (hAPP) and BACE mRNA expression by in situ hybridization in young and old hAPP transgenic mice from two lines: Tg2576, hAPP KM670-671NL (hAPP(Sw)) at 4 and 15 months; and PDAPP, hAPP V717F, at 4 and 11 months. In transgene-positive mice from both lines, hAPP expression was most prominent in cortical, cerebellar, and hippocampal neuronal populations. Cingulate, entorhinal, and hippocampal amyloid burden in transgene-positive 16-month Tg2576 mice was 4 to 8%, and in 12-month PDAPP mice, 2 to 4%; there was no cerebellar amyloid deposition. BACE expression in transgenic and nontransgenic mice was highest in the cerebellar granule cell layer and hippocampal neuronal layers, intermediate in cortex, lower in subcortical regions, and minimal or absent in white matter of the cerebellum. Emulsion-dipped sections confirmed a predominantly neuronal pattern of expression. The amount of hybridization signal did not differ between transgenic and nontransgenic mice, or young and old mice, within each line. Thus, hAPP and endogenous BACE expression in similar anatomical localizations allow for processing of hAPP and Abeta formation in hAPP transgenic mice, but these are modified by additional age-related and anatomical factors.

MeSH Terms
Aging Amyloid Precursor Protein Secretases Amyloid beta-Peptides/metabolism Amyloid beta-Protein Precursor/genetics,metabolism Animals Aspartic Acid Endopeptidases/genetics,metabolism Cerebellum/cytology,metabolism Cerebral Cortex/cytology,metabolism Endopeptidases Female Gene Expression Hippocampus/cytology,metabolism Humans In Situ Hybridization Male Mice Mice, Inbred C57BL Mice, Inbred DBA Mice, Transgenic Neurons/metabolism RNA, Messenger/genetics,metabolism
Chemicals
Amyloid beta-Peptides Amyloid beta-Protein Precursor RNA, Messenger Amyloid Precursor Protein Secretases Endopeptidases Aspartic Acid Endopeptidases BACE2 protein, human BACE1 protein, human Bace1 protein, mouse
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Irizarry M C
Alzheimer Disease Research Unit, Massachusetts General Hospital, Charlestown, MA 02129, USA.
Locascio J J
Hyman B T
References (26)
26 references, click to expand
  1. Expression analysis of BACE2 in brain and peripheral tissues.
    J Biol Chem. 2000 Jul 7;275(27):20647-51 PMID: 10749877
  2. Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity.
    Nature. 1999 Dec 2;402(6761):533-7 PMID: 10591213
  3. Apolipoprotein E affects the amount, form, and anatomical distribution of amyloid beta-peptide deposition in homozygous APP(V717F) transgenic mice.
    Acta Neuropathol. 2000 Nov;100(5):451-8 PMID: 11045665
  4. Differential regional and cellular distribution of beta-amyloid precursor protein messenger RNAs containing and lacking the Kunitz protease inhibitor domain in the brain of human, rat and mouse.
    Neuroscience. 1993 Mar;53(1):267-95 PMID: 8469310
  5. Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F beta-amyloid precursor protein and Alzheimer's disease.
    J Neurosci. 1996 Sep 15;16(18):5795-811 PMID: 8795633
  6. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice.
    Science. 1996 Oct 4;274(5284):99-102 PMID: 8810256
  7. In situ hybridization analysis of presenilin 1 mRNA in Alzheimer disease and in lesioned rat brain.
    Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):14020-4 PMID: 8943053
  8. Developmental regulation of presenilin mRNA expression parallels notch expression.
    J Neuropathol Exp Neurol. 1997 Jan;56(1):40-4 PMID: 8990127
  9. Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease.
    Proc Natl Acad Sci U S A. 1997 Feb 18;94(4):1550-5 PMID: 9037091
  10. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology.
    Proc Natl Acad Sci U S A. 1997 Nov 25;94(24):13287-92 PMID: 9371838
  11. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes.
    Nat Med. 1998 Jan;4(1):97-100 PMID: 9427614
  12. Predominance of neuronal mRNAs in individual Alzheimer's disease senile plaques.
    Ann Neurol. 1999 Feb;45(2):174-81 PMID: 9989619
  13. Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain.
    J Biol Chem. 1999 Mar 5;274(10):6483-92 PMID: 10037741
  14. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity.
    Nature. 1999 Apr 8;398(6727):513-7 PMID: 10206644
  15. Amyloid production and deposition in mutant amyloid precursor protein and presenilin-1 yeast artificial chromosome transgenic mice.
    Nat Neurosci. 1999 Aug;2(8):695-7 PMID: 10412057
  16. Purification and cloning of amyloid precursor protein beta-secretase from human brain.
    Nature. 1999 Dec 2;402(6761):537-40 PMID: 10591214
  17. Identification of a novel aspartic protease (Asp 2) as beta-secretase.
    Mol Cell Neurosci. 1999 Dec;14(6):419-27 PMID: 10656250
  18. Alzheimer disease: mouse models pave the way for therapeutic opportunities.
    Arch Neurol. 2000 Feb;57(2):176-81 PMID: 10681074
  19. Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model.
    Ann Neurol. 2000 Jun;47(6):739-47 PMID: 10852539
  20. Abeta deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse.
    J Neurosci. 1997 Sep 15;17(18):7053-9 PMID: 9278541
  21. APPSw transgenic mice develop age-related A beta deposits and neuropil abnormalities, but no neuronal loss in CA1.
    J Neuropathol Exp Neurol. 1997 Sep;56(9):965-73 PMID: 9291938
  22. Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins.
    Neuron. 1997 Oct;19(4):939-45 PMID: 9354339
  23. Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition.
    Nat Genet. 1997 Nov;17(3):263-4 PMID: 9354781
  24. Presenilin-1, amyloid precursor protein and amyloid precursor-like protein 2 mRNA levels in human superior frontal cortex during aging.
    Neurosci Lett. 1997 Oct 10;235(1-2):17-20 PMID: 9389585
  25. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE.
    Science. 1999 Oct 22;286(5440):735-41 PMID: 10531052
  26. BACE2, a beta -secretase homolog, cleaves at the beta site and within the amyloid-beta region of the amyloid-beta precursor protein.
    Proc Natl Acad Sci U S A. 2000 Aug 15;97(17):9712-7 PMID: 10931940
Article Info
Journal
The American journal of pathology
Abbr.
Am J Pathol
ISSN
0002-9440
Published
2001-01-00
Pages
173-7
Language
English
Region
United States
NLM ID
0370502
PMCID
PMC1850271
Subset
IM
Grants
NIA NIH HHS · P50 AG005134 · United States
NIA NIH HHS · AG00793 · United States
NIA NIH HHS · AG05134 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]